GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Endocrinology

• Publication date

  2012-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/en.2011-1443PMID 22128031PMCID PMC3275387
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hyperphagia and Increased Fat Accumulation in Two Models of Chronic CNS Glucagon-Like Peptide-1 Loss of Function

  2011cited by this paper
• Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation.

  2011cited by this paper
• Glucagon-Like Peptide 1 Receptors in Nucleus Accumbens Affect Food Intake

  2011cited by this paper
• Reward mechanisms in obesity: new insights and future directions.

  2011cited by this paper
• Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4.

  2011cited by this paper
• The role of the central ghrelin system in reward from food and chemical drugs.

  2011cited by this paper
• Comparative Effects of the Long‐Acting GLP‐1 Receptor Ligands, Liraglutide and Exendin‐4, on Food Intake and Body Weight Suppression in Rats

  2011cited by this paper
• Role of the glucagon-like-peptide-1 receptor in the control of energy balance.

  2010cited by this paper
• Ascending projections from the caudal visceral nucleus of the solitary tract to brain regions involved in food intake and energy expenditure.

  2010influential reference
• GABA-A and GABA-B receptors mediate feeding elicited by the GABA-B agonist baclofen in the ventral tegmental area and nucleus accumbens shell in rats: reciprocal and regional interactions.

  2010cited by this paper
• Liraglutide: the therapeutic promise from animal models

  2010cited by this paper
• Metabolic hormones, dopamine circuits, and feeding.

  2010cited by this paper
• The limbic circuitry underlying cocaine seeking encompasses the PPTg/LDT

  2009cited by this paper
• Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling.

  2009cited by this paper
• Incretin-based therapies for type 2 diabetes mellitus

  2009influential reference
• Feeding association between the nucleus of the solitary tract and the ventral tegmental area.

  2009cited by this paper
• Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.

  2009cited by this paper
• Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis.

  2009cited by this paper
• Ghrelin and Dopamine: New Insights on the Peripheral Regulation of Appetite

  2009cited by this paper
• Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.

  2009cited by this paper
• Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6).

  2009cited by this paper
• Parabrachial Coding of Sapid Sucrose:

  2009cited by this paper
• From taste hedonics to motivational drive: central μ-opioid receptors and binge-eating behaviour.

  2009cited by this paper
• Conditioned nausea in rats: assessment by conditioned disgust reactions, rather than conditioned taste avoidance.

  2008cited by this paper
• Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation.

  2008cited by this paper
• Real-time chemical responses in the nucleus accumbens differentiate rewarding and aversive stimuli

  2008cited by this paper
• Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the rat.

  2008cited by this paper
• Imaging obesity: fMRI, food reward, and feeding.

  2007cited by this paper
• The GLP-1 agonist exendin-4 reduces food intake in nonhuman primates through changes in meal size.

  2007cited by this paper
• The physiology of glucagon-like peptide 1.

  2007cited by this paper
• Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei.

  2007cited by this paper
• Leptin and the control of food intake: neurons in the nucleus of the solitary tract are activated by both gastric distension and leptin.

  2007cited by this paper
• Liraglutide, a Long-Acting Glucagon-Like Peptide-1 Analog, Reduces Body Weight and Food Intake in Obese Candy-Fed Rats, Whereas a Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin, Does Not

  2007cited by this paper
• Biology of incretins: GLP-1 and GIP.

  2007cited by this paper
• Liraglutide, a Once‐daily Human Glucagon‐like Peptide‐1 Analog, Minimizes Food Intake in Severely Obese Minipigs

  2007cited by this paper
• Gustatory reward and the nucleus accumbens.

  2006cited by this paper
• Leptin receptor signaling in midbrain dopamine neurons regulates feeding.

  2006cited by this paper
• Leptin regulation of the mesoaccumbens dopamine pathway.

  2006cited by this paper
• Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes

  2006cited by this paper
• Signals for nausea and emesis: Implications for models of upper gastrointestinal diseases.

  2006cited by this paper
• Role of brain dopamine in food reward and reinforcement

  2006cited by this paper
• Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.

  2005cited by this paper
• Brain, appetite and obesity.

  2005cited by this paper
• How to modify the food environment.

  2005cited by this paper
• Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes.

  2004cited by this paper
• Opioid receptor subtype antagonists differentially alter GABA agonist-induced feeding elicited from either the nucleus accumbens shell or ventral tegmental area regions in rats.

  2004cited by this paper
• Obesity and the food environment: dietary energy density and diet costs.

  2004cited by this paper
• Dopamine Operates as a Subsecond Modulator of Food Seeking

  2004cited by this paper
• Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens.

  2004cited by this paper
• Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons.

  2003cited by this paper
• Reward without Dopamine

  2003cited by this paper
• Effects of the opioid antagonist naltrexone on feeding induced by DAMGO in the ventral tegmental area and in the nucleus accumbens shell region in the rat.

  2003cited by this paper
• The Diverse Roles of Specific GLP-1 Receptors in the Control of Food Intake and the Response to Visceral Illness

  2002cited by this paper
• Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus.

  1999cited by this paper
• Interoceptive stress activates glucagon-like peptide-1 neurons that project to the hypothalamus.

  1999cited by this paper
• Distribution of pre‐pro‐glucagon and glucagon‐like peptide‐1 receptor messenger RNAs in the rat central nervous system

  1999cited by this paper
• PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats.

  1998cited by this paper
• Intracerebroventricular glucagon-like peptide-1 (7-36) amide inhibits sham feeding in rats without eliciting satiety.

  1998cited by this paper
• The Neurobiology of Addiction

  1997cited by this paper
• Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem.

  1997cited by this paper
• A role for glucagon-like peptide-1 in the central regulation of feeding

  1996cited by this paper
• Neurobiology of addiction.

  1996cited by this paper
• Ventral tegmental area opioid mechanisms and modulation of ingestive behavior.

  1995cited by this paper
• Distribution of GLP‐1 Binding Sites in the Rat Brain: Evidence that Exendin‐4 is a Ligand of Brain GLP‐1 Binding Sites

  1995cited by this paper
• Fluoro-Gold: a new fluorescent retrograde axonal tracer with numerous unique properties.

  1986cited by this paper
• Cholecystokinin and bombesin suppress operant responding for food reward.

  1985cited by this paper
• Microinjections of nanogram amounts of sulfated cholecystokinin octapeptide into the rat nucleus accumbens attenuates brain stimulation reward.

  1984cited by this paper
• The Rat Brain in Stereotaxic Coordinates

  1983influential reference
• Conditioned aversion to saccharin resulting from exposure to gamma radiation.

  1955cited by this paper

• Short- and long-acting GLP-1 receptor agonists decrease female sexual behaviors in experienced rodents.

  2026cites this paper
• GLP-1 receptor agonists for smoking cessation: a narrative review of weight management potential.

  2026cites this paper
• Comparative safety of glucose‐lowering medications on depression in adults with type 2 diabetes

  2026cites this paper
• From cellular cognition to psychopathology: a three-level framework of biological decision-making

  2026cites this paper
• Do no harm: managing nausea and vomiting in GLP-1 based obesity therapies

  2026cites this paper
• The science of safety: adverse effects of GLP-1 receptor agonists as glucose-lowering and obesity medications

  2026cites this paper
• Quieting "Food Noise": How GLP-1s and Mindfulness Rewire the Default Mode Network (DMN) and Reward Circuits

  2026cites this paper
• Translational Perspectives on Binge-Eating: Insights from Animal Models.

  2026cites this paper
• Антиаддиктивный потенциал двойного агониста инкретиновых рецепторов тирзепатида в тесте на эмоциональное переедание, вызванное внутримозговой самостимуляцией

  2026cites this paper
• Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists Following Bariatric Surgery: A Systematic Review and Meta-Analysis.

  2026cites this paper
• GLP-1 physiology and pharmacology along the gut-brain axis

  2026cites this paper
• Gut distension evokes rapid neural dynamics in vagal and hindbrain populations of larval zebrafish

  2026cites this paper
• Potential role of glucagon like peptide 1 in taste receptors

  2026cites this paper
• Neuromodulation using Bioelectronics-enabled therapies to combat insulin resistance and its comorbidities

  2026cites this paper
• Lateral Septum as a Key Integrative Regulator of Feeding: Role of the GLP‐1/GLP‐1R System

  2025cites this paper
• Neurobiological Mechanisms and Therapeutic Potential of Glucagon-like Peptide-1 Receptor Agonists in Binge Eating Disorder: A Narrative Review

  2025cites this paper
• Mechanisms of GLP-1 receptor agonist-induced weight loss: A review of central and peripheral pathways in appetite and energy regulation.

  2025cites this paper
• Does semaglutide reduce alcohol intake in Danish patients with alcohol use disorder and comorbid obesity? Trial protocol of a randomised, double-blinded, placebo-controlled clinical trial (the SEMALCO trial)

  2025cites this paper
• GLP-1 Receptor Agonists and Research to Treat Overeating and Substance Use Disorders

  2025cites this paper
• The estrous cycle moderates the food and body weight suppressive effects of glucagon‐like peptide‐1 receptor agonism

  2025cites this paper
• Integration of Glucagon-like Peptide 1 Receptor Actions through the Central Amygdala.

  2025cites this paper
• GLP-1RA and reduced mortality, cardiovascular and psychiatric risks in psoriasis: a large-scale cohort study.

  2025cites this paper
• The (dys)regulation of energy storage in obesity.

  2025cites this paper
• An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking

  2025cites this paper
• Mechanisms of GLP-1 in Modulating Craving and Addiction: Neurobiological and Translational Insights

  2025influential citation
• Cardiovascular and kidney outcomes of GLP‐1 receptor agonists in adults with obesity: A target trial emulation study

  2025cites this paper
• Use of semaglutide in a 54-year-old patient with cocaine abuse and weight loss: a case report

  2025cites this paper
• Development and validation of the Food Noise Questionnaire

  2025cites this paper
• Psychotropic effects of GLP-1R agonists.

  2025cites this paper
• Effects of GLP‐1 Receptor Agonists in Alcohol Use Disorder

  2025cites this paper
• The Influence of the Sympathetic Nervous System on Cardiometabolic Health in Response to Weight Gain or Weight Loss

  2025cites this paper
• The Potential Utility of GLP-1 Receptor Agonist Medications for Addiction Treatment: A Narrative Review of Clinical and Epidemiological Evidence

  2025cites this paper
• Review Article: GLP‐1 Receptor Agonists and Glucagon/GIP/GLP‐1 Receptor Dual or Triple Agonists—Mechanism of Action and Emerging Therapeutic Landscape in MASLD

  2025cites this paper
• Blood phosphatidylethanol measurements indicate GLP‐1 receptor stimulation causes delayed decreases in alcohol consumption

  2025cites this paper
• GLP-1 Analogues in the Neurobiology of Addiction: Translational Insights and Therapeutic Perspectives

  2025cites this paper
• Therapeutic Potential of the Novel GLP-1 Receptor Agonist Semaglutide in Alcohol Use Disorder

  2025cites this paper
• Oxytocin as a modulator of adaptive behavior: integrating ingestive and social mechanisms.

  2025cites this paper
• The neurobiology of overeating.

  2025cites this paper
• Dopaminergic Pathways in Neuroplasticity After Stroke and Vagus Nerve Stimulation

  2025cites this paper
• The gut and heart’s role in reward processing

  2025cites this paper
• Effect of Central UAG on Metabolic Associated Fatty Liver Disease: a Possible Mechanism involving in GLP-1 Neural Pathway.

  2025cites this paper
• What's the occasion? Phasic dopamine signaling and interoception.

  2025cites this paper
• Repurposing Incretin Therapies: A Narrative Review of Emerging Indications Across Cardiometabolic, Liver, Kidney, Neurological, Psychiatric, and Other Systems.

  2025cites this paper
• Psychological and behavioral effects of GLP-1 and GIP agonists in weight loss: a comprehensive review

  2025cites this paper
• The GLP-1R Agonist Semaglutide Reduces Motivated Running and Alters Dopamine Dynamics in the Nucleus Accumbens

  2025cites this paper
• Vagus Nerve Stimulation in Movement Disorders, from Principles to a Systematic Review of Evidence

  2025cites this paper
• The Genetic Blueprint of Obesity: From Pathogenesis to Novel Therapies

  2025cites this paper
• Advantage of Semaglutide: Comprehensive Analysis of Metabolic Impact of Semaglutide‐Treated and Pair‐Fed Rats

  2025cites this paper
• Characterization of NTS‐to‐VTA projection neurons reveals higher‐order synaptic organization and distinct responsiveness to cholecystokinin

  2025influential citation
• The interface between the homeostatic and hedonic energy balance circuitries in the regulation of appetitive behavior: A focus on steroidogenic factor-1/pituitary adenylate cyclase-activating polypeptide neurons in the hypothalamic ventromedial nucleus.

  2025cites this paper
• Mechanistic and translational insights from preclinical cocaine choice procedures on the economic substitutability of cocaine and nondrug reinforcers.

  2025cites this paper
• Brain-Derived GLP-1—Understanding the Physiological Function and Anti-obesity Potential of Preproglucagon Neurons

  2025cites this paper
• GLP-1 Signalling as a Therapeutic Avenue in Parkinson’s Disease: A Comprehensive Review

  2025cites this paper
• Effect of dietary stimulation on acute changes in GLP-1, alcohol responses, craving, and attentional bias: a randomized, placebo-controlled laboratory study.

  2025cites this paper
• PACAP Signaling Network in the Nucleus Accumbens Core Regulates Reinstatement Behavior in Rat

  2025cites this paper
• Populations of Hindbrain Glucagon-Like Peptide 1 (GLP1) Neurons That Innervate the Hypothalamic PVH, Thalamic PVT, or Limbic Forebrain BST Have Axon Collaterals That Reach All Central Regions Innervated by GLP1 Neurons

  2024cites this paper
• Role of lifestyle and glucagon‐like peptide‐1 receptor agonists for weight loss in obesity, type 2 diabetes and steatotic liver diseases

  2024influential citation
• The emerging role of glucagon-like peptide-1 in binge eating.

  2024cites this paper
• An endogenous GLP-1 circuit engages VTA GABA neurons to regulate mesolimbic dopamine neurons and attenuate cocaine seeking

  2024cites this paper
• Neurocircuitry underlying the actions of glucagon-like peptide 1 and peptide YY3-36 in the suppression of food, drug-seeking, and anxiogenesis.

  2024cites this paper
• Glucagon-Like Peptide 1: An Introduction and Possible Implications for Neuropsychiatry.

  2024cites this paper
• Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population

  2024cites this paper
• Acute and Chronic Exposure to Linagliptin, a Selective Inhibitor of Dipeptidyl Peptidase-4 (DPP-4), Has an Effect on Dopamine, Serotonin and Noradrenaline Level in the Striatum and Hippocampus of Rats

  2024cites this paper
• Synthetic exendin-4 disrupts responding to reward predictive incentive cues in male rats

  2024cites this paper
• GLP-1 receptor agonist exenatide uncouples food intake from hedonic and anticipatory regulation in non-human primates: insights from an operant meal schedule paradigm

  2024cites this paper
• Acupuncture for obesity and related diseases: Insight for regulating neural circuit.

  2024cites this paper
• Metabolic factors modulate effort-based decision-making in major depressive disorder.

  2024cites this paper
• Are glucagon-like peptide-1 receptor agonists anti-consummatory drugs?

  2024cites this paper
• Glucagon‐Like Peptide‐1 Links Ingestion, Homeostasis, and the Heart

  2024influential citation
• Targeting central pathway of Glucose‐Dependent Insulinotropic Polypeptide, Glucagon and Glucagon‐like Peptide‐1 for metabolic regulation in obesity and type 2 diabetes

  2024cites this paper
• Examining the Potential Applicability of Orexigenic and Anorexigenic Peptides in Veterinary Medicine for the Management of Obesity in Companion Animals

  2024cites this paper
• Mechanisms of probiotic modulation of ovarian sex hormone production and metabolism: a review.

  2024cites this paper
• Novel neural pathways targeted by GLP-1R agonists and bariatric surgery

  2024cites this paper
• From Mammals to Insects: Exploring the Genetic and Neural Basis of Eating Behavior.

  2024cites this paper
• Hunting for heroes: Brain neurons mediating GLP-1R agonists in obesity treatment.

  2024cites this paper
• A Brain Reward Circuit Inhibited By Next-Generation Weight Loss Drugs

  2024cites this paper
• Review article: Pharmacologic management of obesity ‐ updates on approved medications, indications and risks

  2024cites this paper
• GLP-1, GIP, and Glucagon Agonists for Obesity Treatment: A Hunger Perspective.

  2024cites this paper
• GLP-1 programs the neurovascular landscape.

  2024cites this paper
• Gut Hormones: Possible Mediators of Addictive Disorders?

  2024cites this paper
• Amelioration of social impairments in autism: Possible role of vagal afferent stimulation in modification of the prefrontal-amygdala connectivity

  2024cites this paper
• Semaglutide and smoking cessation in individuals with type 2 diabetes mellitus: there is no smoke without fire!

  2024cites this paper
• Neurolipidomics in schizophrenia: a not so well-oiled machine.

  2024cites this paper
• Neural processing of sweet taste in reward regions is reduced following bariatric surgery

  2024influential citation
• The GLP-1 receptor agonist exendin-4 reduces taurine and glycine in nucleus accumbens of male rats, an effect tentatively involving the nucleus tractus solitarius

  2024cites this paper
• What Is the Role of Glucagon-Like Peptide 1 Signaling in the Nervous System and Its Potential Neuroprotective Effects?

  2024cites this paper
• Molecular Mechanisms behind Obesity and Their Potential Exploitation in Current and Future Therapy

  2024cites this paper
• Examining Weight Suppression, Leptin Levels, Glucagon-Like Peptide 1 Response, and Reward-Related Constructs in Severity and Maintenance of Bulimic Syndromes: Protocol and Sample Characteristics for a Cross-Sectional and Longitudinal Study

  2024cites this paper
• Association between glucagon-like peptide-1 receptor agonists use and change in alcohol consumption: a systematic review

  2024cites this paper
• Association of Semaglutide With Tobacco Use Disorder in Patients With Type 2 Diabetes

  2024cites this paper
• Potential role of glucagon-like peptide-1 (GLP-1) receptor agonists in substance use disorder: A systematic review of randomized trials.

  2024cites this paper
• Effect of acute treatment with the glucagon-like peptide-1 receptor agonist, liraglutide, and estrus phase on cue- and drug-induced fentanyl seeking in female rats

  2024cites this paper
• Metformin and the Liver: Unlocking the Full Therapeutic Potential

  2024cites this paper
• CCK-sensitive C fibers activate NTS leptin receptor-expressing neurons via NMDA receptors

  2023cites this paper
• The interplay between leptin, glucocorticoids, and GLP1 regulates food intake and feeding behaviour

  2023cites this paper
• Dopamine neuron activity evoked by sucrose and sucrose‐predictive cues is augmented by peripheral and central manipulations of glucose availability

  2023cites this paper
• New perspectives on the use of glucagon-like peptide 1 in diseases of the central nervous system

  2023cites this paper
• Delayed estrogen actions diminish food consumption without changing food approach, motor activity, or hypothalamic activation elicited by corticostriatal µ-opioid signaling

  2023cites this paper
• Linking drug and food addiction: an overview of the shared neural circuits and behavioral phenotype

  2023cites this paper
• Gut–vagus–NTS neural pathway in controlling feeding behaviors

  2023cites this paper